{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T06:27:17Z","timestamp":1782455237286,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.revmed.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:17:29Z","timestamp":1741609049000},"page":"257-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neurolymphomatoses"],"prefix":"10.1016","volume":"46","author":[{"given":"Fanny","family":"Urbain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Bicart-See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Labeyrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-617X","authenticated-orcid":false,"given":"Nicolas","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2025.02.003_bib0200","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/neuonc\/nop021","article-title":"Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab","volume":"12","author":"Gan","year":"2010","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0205","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/bloodadvances.2020003666","article-title":"Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era","volume":"5","author":"Khurana","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2025.02.003_bib0210","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jns.12541","article-title":"Neurolymphomatosis: involvement of peripheral nervous system revealing hematologic malignancy, a report of nine cases","volume":"28","author":"Ducatel","year":"2023","journal-title":"J Peripheral Nervous Sys"},{"key":"10.1016\/j.revmed.2025.02.003_bib0215","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1215\/15228517-5-2-104","article-title":"Neurolymphomatosis","volume":"5","author":"Baehring","year":"2003","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0220","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","article-title":"Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report","volume":"115","author":"Grisariu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2025.02.003_bib0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/PPO.0b013e31826c5ad5","article-title":"Diagnosis and management of neurolymphomatosis","volume":"18","author":"Baehring","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.revmed.2025.02.003_bib0230","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.clinimag.2016.08.014","article-title":"Neurolymphomatosis of the peripheral nervous system: a case report and review of the literature","volume":"40","author":"Sideras","year":"2016","journal-title":"Clin Imaging"},{"key":"10.1016\/j.revmed.2025.02.003_bib0235","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2014.04.030","article-title":"Primary neurolymphomatosis diagnosis and treatment: a retrospective study","volume":"342","author":"Lagarde","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2025.02.003_bib0240","doi-asserted-by":"crossref","first-page":"e209777","DOI":"10.1212\/WNL.0000000000209777","article-title":"Neurologic clinical, electrophysiologic, and pathologic characteristics of primary vs. secondary neurolymphomatosis","volume":"103","author":"Skolka","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2025.02.003_bib0245","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.revmed.2021.06.013","article-title":"Neuropathies p\u00e9riph\u00e9riques associ\u00e9es aux syndromes lymphoprolif\u00e9ratifs\u00a0: spectre clinique et d\u00e9marche diagnostique","volume":"42","author":"Pacoureau","year":"2021","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2025.02.003_bib0250","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/brain\/awt193","article-title":"Clinicopathological features of neuropathy associated with lymphoma","volume":"136","author":"Tomita","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2025.02.003_bib0255","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/brain\/118.5.1233","article-title":"Non-Hodgkin malignant lymphomas and peripheral neuropathies\u201413 cases","volume":"118","author":"Vallat","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2025.02.003_bib0260","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1080\/10428194.2021.1889535","article-title":"Inflammatory demyelinating polyneuropathies and lymphoma: clues to diagnosis and therapy","volume":"62","author":"Noel","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.revmed.2025.02.003_bib0265","first-page":"115","article-title":"Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"79","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2025.02.003_bib0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/13506129.2011.574354036","article-title":"Varied patterns of inaugural light-chain (AL) amyloid polyneuropathy: a monocentric study of 24 patients","volume":"18","author":"Adams","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.revmed.2025.02.003_bib0275","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp-2017-316715","article-title":"Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features","volume":"89","author":"Svahn","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2025.02.003_bib0280","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/WCO.0000000000000475","article-title":"Paraneoplastic neuropathies","volume":"30","author":"Antoine","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0285","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00415-018-9110-6","article-title":"POEMS syndrome: clinical update","volume":"266","author":"Brown","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0290","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneurol.2017.42","article-title":"The nonsystemic vasculitic neuropathies","volume":"13","author":"Collins","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0295","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ajh.24745","article-title":"Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia","volume":"92","author":"Sidana","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0300","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1097\/MD.0000000000000394","article-title":"Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case series","volume":"94","author":"Duchesne","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2025.02.003_bib0305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neurol.2010.03.015","article-title":"Prise en charge des biopsies musculaires et nerveuses. Recommandations formalis\u00e9es d\u2019experts sous l\u2019\u00e9gide de la Soci\u00e9t\u00e9 fran\u00e7aise de neuropathologie, de la Soci\u00e9t\u00e9 fran\u00e7aise de myologie et de l\u2019Association fran\u00e7aise contre les myopathies","volume":"166","author":"Uro-Coste","year":"2010","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00401-011-0804-4","article-title":"Nerve biopsy: requirements for diagnosis and clinical value","volume":"121","author":"Vallat","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0315","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.leu.2404482","article-title":"Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"21","author":"Langerak","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2025.02.003_bib0320","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jns.12295","article-title":"Peripheral nervous system involvement in lymphomas","volume":"24","author":"Briani","year":"2019","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.revmed.2025.02.003_bib0325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"Van den Bergh","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0330","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/MNM.0b013e3283561881","article-title":"Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis","volume":"33","author":"Salm","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.revmed.2025.02.003_bib0335","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s00256-019-3145-3","article-title":"B-cell peripheral neurolymphomatosis: MRI and 18F-FDG PET\/CT imaging characteristics","volume":"48","author":"DeVries","year":"2019","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0340","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/MNM.0000000000000181","article-title":"Usefulness of 18F-FDG PET\/CT in the detection of neurolymphomatosis:","volume":"35","author":"Zhou","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.revmed.2025.02.003_bib0345","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/ene.13868","article-title":"Diagnostic usefulness of plexus magnetic resonance imaging in chronic inflammatory demyelinating polyradiculopathy without electrodiagnostic criteria of demyelination","volume":"26","author":"Fargeot","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0350","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cnp.2023.04.003","article-title":"Utility of nerve ultrasound in the management of primary neurolymphomatosis: case report and review of the literature","volume":"8","author":"Wada","year":"2023","journal-title":"Clin Neurophysiol Pract"},{"key":"10.1016\/j.revmed.2025.02.003_bib0355","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/WCO.0000000000001317","article-title":"Blood and cerebrospinal fluid biomarkers in neuro-oncology","volume":"37","author":"Rud\u00e0","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0360","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3343\/alm.2024.0257","article-title":"Feasibility of circulating tumor DNA detection in the cerebrospinal fluid of patients with central nervous system involvement in large B cell lymphoma","volume":"45","author":"Kim","year":"2025","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.revmed.2025.02.003_bib0365","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/JBM.S459123","article-title":"Clinical and genomic profile of primary cranial neurolymphomatosis","volume":"15","author":"Wolf","year":"2024","journal-title":"JBM"},{"key":"10.1016\/j.revmed.2025.02.003_bib0370","doi-asserted-by":"crossref","first-page":"113272","DOI":"10.1016\/j.expneurol.2020.113272","article-title":"Biology of the human blood-nerve barrier in health and disease","volume":"328","author":"Ubogu","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0375","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.devcel.2023.01.002","article-title":"Characterization of the structure and control of the blood-nerve barrier identifies avenues for therapeutic delivery","volume":"58","author":"Malong","year":"2023","journal-title":"Dev Cell"},{"key":"10.1016\/j.revmed.2025.02.003_bib0380","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2015-05-647834","article-title":"Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse","volume":"126","author":"Bernard","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2025.02.003_bib0385","doi-asserted-by":"crossref","first-page":"707285","DOI":"10.3389\/fonc.2021.707285","article-title":"Efficacy and safety of ibrutinib in central nervous system lymphoma: a PRISMA-compliant single-arm meta-analysis","volume":"11","author":"Lv","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.revmed.2025.02.003_bib0195","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12185-018-02586-7","article-title":"Limited efficacy of high-dose methotrexate in patients with neurolymphomatosis","volume":"109","author":"Kobayashi","year":"2019","journal-title":"Int J Hematol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866325000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866325000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T14:39:34Z","timestamp":1747319974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866325000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0248866325000487"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2025.02.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurolymphomatoses","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}